Lundy Steve 4
4 · AspenBio Pharma, Inc. · Filed May 18, 2012
Insider Transaction Report
Form 4
Lundy Steve
DirectorCEO and President
Transactions
- Other
Stock Option (Right to Buy)
2012-05-02−37,658→ 42,342 totalExercise: $11.40Exp: 2020-03-24→ Common Stock (37,658 underlying) - Other
Stock Option (Right to Buy)
2012-05-02−5,563→ 12,437 totalExercise: $2.95Exp: 2021-01-05→ Common Stock (5,563 underlying) - Other
Stock Option (Right to Buy)
2012-05-02−12,834→ 67,166 totalExercise: $3.40Exp: 2021-07-08→ Common Stock (12,834 underlying)
Footnotes (4)
- [F1]These stock options were transferred to the reporting person's ex-spouse pursuant to a final divorce decree.
- [F2]The transferred stock options to purchase 37,658 shares of common stock became exercisable as to 10,000 of the shares on May 5, 2010, as to 13,334 of the shares on March 24, 2011, as to 12,278 of the shares on March 24, 2012, and shall become exercisable as to 2,046 of the shares on March 24, 2013.
- [F3]The transferred stock options to purchase 5,563 shares of common stock became exercisable as to 3,000 of the shares on January 5, 2012, and shall become exercisable as to 1,538 of the shares on January 5, 2013, and as to 1,025 of the shares on January 5, 2014.
- [F4]The transferred stock options to purchase 12,834 shares of common stock shall become exercisable as to 7,000 on July 8, 2012, as to 3,500 of the shares on July 8, 2013, and as to 2,334 of the shares on July 8, 2014.